The insertion/deletion (I/D) polymorphism in the Angiotensin-converting enzyme gene and cancer risk: a meta-analysis

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Zhang, Yonggang ^a   He, Jie ^a   Deng, Yao ^a   Zhang, Jie ^b   Li, Xiaobo ^a,c   Xiang, Zhangpeng ^a   Huang, Honglang ^a   Tian, Can ^a   Huang, Jin ^a   Fan, Hong ^a  

^a SICHUAN UNIVERSITY   (China)

^b BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^c The 452nd Military Hospital of China   (China)

Author keywords

Angiotensin converting enzyme; Cancer; Meta analysis; Polymorphism; Risk

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ACE PROTEIN, HUMAN;

ARTICLE; ASIAN; BREAST CANCER; CANCER PATIENT; CANCER RISK; COLORECTAL CANCER; EUROPEAN AMERICAN; GENE DELETION; GENE INSERTION; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; HUMAN; LUNG CANCER; PROSTATE CANCER; STOMACH CANCER; CAUCASIAN; GENETIC PREDISPOSITION; GENETICS; INDEL MUTATION; META ANALYSIS; NEOPLASM; RISK; STATISTICS;

ASIAN CONTINENTAL ANCESTRY GROUP; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INDEL MUTATION; NEOPLASMS; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RISK;

EID: 83155163792     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-159     Document Type: Article

References (50)

1. Eriksson U, Danilczyk U, Penninger JM. Just the beginning: novel functions for angiotensin-converting enzymes. Curr Biol 2002, 12:R745-R752. 10.1016/S0960-9822(02)01255-1, 12419208.
2. Vairaktaris E, Yapijakis C, Tsigris C, Vassiliou S, Derka S, Nkenke E, Spyridonidou S, Vylliotis A, Vorris E, Ragos V, et al. Association of angiotensin-converting enzyme gene insertion/deletion polymorphism with increased risk for oral cancer. Acta Oncol 2007, 46:1097-1102. 10.1080/02841860701373579, 17851834.
3. Nacak M, Nacak I, Sanli M, Ozkur M, Pektas M, Aynacioglu AS. Association of angiotensin converting enzyme gene insertion/deletion polymorphism with lung cancer in Turkey. Cancer Genet Cytogenet 2010, 198:22-26. 10.1016/j.cancergencyto.2009.11.019, 20303010.
4. Sugimoto M, Furuta T, Shirai N, Ikuma M, Sugimura H, Hishida A. Influences of chymase and angiotensin I-converting enzyme gene polymorphisms on gastric cancer risks in Japan. Cancer Epidemiol Biomarkers Prev 2006, 15:1929-1934. 10.1158/1055-9965.EPI-06-0339, 17035401.
5. Yigit B, Bozkurt N, Narter F, Yilmaz H, Yucebas E, Isbir T. Effects of ACE I/D polymorphism on prostate cancer risk, tumor grade and metastatis. Anticancer Res 2007, 27:933-936.
6. Haiman CA, Henderson SO, Bretsky P, Kolonel LN, Henderson BE. Genetic variation in angiotensin I-converting enzyme (ACE) and breast cancer risk: the multiethnic cohort. Cancer Res 2003, 63:6984-6987.
7. Rocken C, Lendeckel U, Dierkes J, Westphal S, Carl-McGrath S, Peters B, Kruger S, Malfertheiner P, Roessner A, Ebert MP. The number of lymph node metastases in gastric cancer correlates with the angiotensin I-converting enzyme gene insertion/deletion polymorphism. Clin Cancer Res 2005, 11:2526-2530. 10.1158/1078-0432.CCR-04-1922, 15814629.
8. Kitsios G, Zintzaras E. ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation. BMC Med Genet 2009, 10:50. 2700093, 19497121.
9. Vasku V, Vasku JA, Goldbergova MP, Vasku A. Association of variants in angiotensin-converting enzyme and endothelin-1 genes with phototherapy in cutaneous T-cell lymphoma. Acta Dermatovenerol Alp Panonica Adriat 2004, 13:111-116. 118.
10. Goto Y, Ando T, Nishio K, Ishida Y, Kawai S, Goto H, Hamajima N. The ACE gene polymorphism is associated with the incidence of gastric cancer among H. pylori seropositive subjects with atrophic gastritis. Asian Pac J Cancer Prev 2005, 6:464-467.
11. Wang HW, Nie ZS, Duan YZ, Liu DD, Han ZH, Zhang XH, Hua B. Association between polymorphism in ACE gene with lung cancer and COPD patients(Chinese). Bei Jing Yi Xue 2000, 22:364-365.
12. van der Knaap R, Siemes C, Coebergh JW, van Duijn CM, Hofman A, Stricker BH. Renin-angiotensin system inhibitors, angiotensin I-converting enzyme gene insertion/deletion polymorphism, and cancer: the Rotterdam Study. Cancer 2008, 112:748-757. 10.1002/cncr.23215, 18181094.
13. Toma M, Cimponeriu D, Apostol P, Stavarachi M, Cojocaru M, Belusica L, Craciun AM, Radu I, Gavrila L. Lack of association between ACE ID polymorphism and colorectal cancer in Romanian patients. Chirurgia (Bucur) 2009, 104:553-556.
14. Arima H, Kiyohara Y, Tanizaki Y, Nakabeppu Y, Kubo M, Kato I, Sueishi K, Tsuneyoshi M, Fujishima M, Iida M. Angiotensin I-converting enzyme gene polymorphism modifies the smoking-cancer association: the Hisayama Study. Eur J Cancer Prev 2006, 15:196-201. 10.1097/01.cej.0000199506.15571.37, 16679861.
15. Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S, Demirpence M. Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer. Exp Biol Med (Maywood) 2008, 233:32-37.
16. Nikiteas N, Tsigris C, Chatzitheofylaktou A, Yannopoulos A. No association with risk for colorectal cancer of the insertion/deletion polymorphism which affects levels of angiotensin-converting enzyme. In Vivo 2007, 21:1065-1068.
17. Tunny TJ, Xu L, Richardson KA, Stowasser M, Gartside M, Gordon RD. Insertion/deletion polymorphism of the angiotensin-converting enzyme gene and loss of the insertion allele in aldosterone-producing adenoma. J Hum Hypertens 1996, 10:827-830.
18. Sierra DE, Sanchez CJ, Rosales GR, Gutierrez RS, Vazquez CJ, Solano MH, Moran MM. Angiotensin-converting enzyme insertion/deletion and angiotensin type 1 receptor A1166C polymorphisms as genetic risk factors in benign prostatic hyperplasia and prostate cancer. J Renin Angiotensin Aldosterone Syst 2009, 10:241-246. 10.1177/1470320309352800, 20026870.
19. Tong Y, Lin Y, Zhang Y, Yang JY, Zhang YW, Liu HC, Zhang B. Association between TCF7L2 gene polymorphisms and susceptibility to Type 2 Diabetes Mellitus: a large Human Genome Epidemiology (HuGE) review and meta-analysis. BMC Med Genet 2009, 10:15. 2653476, 19228405.
20. Zhao TF, Zhao JP. Association of the apolipoprotein A5 gene -1131 T > C polymorphism with fasting blood lipids: a meta-analysis in 37859 subjects. BMC Med Genet 2010, 10:120.
21. Zhang Y, Zhang J, Huang J, Li X, He C, Tian C, Peng C, Guo L, Xiao Y, Fan H. Polymorphisms in the transforming growth factor-beta1 gene and the risk of asthma: A meta-analysis. Respirology 2010, 15:643-650. 10.1111/j.1440-1843.2010.01748.x, 20409029.
22. Liu L, Zhuang W, Wang C, Chen Z, Wu XT, Zhou Y. Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: A meta-analysis of epidemiological studies. Cytokine 2010, 50:328-334. 10.1016/j.cyto.2010.03.008, 20363644.
23. Zhang YG, Huang J, Zhang J, Li XB, He C, Xiao YL, Tian C, Wan H, Zhao YL, Tsewang YG, et al. RANTES gene polymorphisms and asthma risk: A meta-analysis. Arch Med Res 2010, 41:50-58. 10.1016/j.arcmed.2010.01.002, 20430255.
24. Freitas-Silva M, Pereira D, Coelho C, Bicho M, Lopes C, Medeiros R. Angiotensin I-converting enzyme gene insertion/deletion polymorphism and endometrial human cancer in normotensive and hypertensive women. Cancer Genet Cytogenet 2004, 155:42-46. 10.1016/j.cancergencyto.2004.03.020, 15527901.
25. Koh WP, Yuan JM, Sun CL, van den Berg D, Seow A, Lee HP, Yu MC. Angiotensin I-converting enzyme (ACE) gene polymorphism and breast cancer risk among Chinese women in Singapore. Cancer Res 2003, 63:573-578.
26. Srivastava K, Srivastava A, Mittal B. Angiotensin I-converting enzyme insertion/deletion polymorphism and increased risk of gall bladder cancer in women. Dna Cell Biol 2010, 29:417-422. 10.1089/dna.2010.1033, 20438364.
27. Alves CS, Ribeiro DNS, Nogueira-de-Souza NC, Valleta DCC, Massad CA, Juvenal LJ, Vieira GM, Guerreiro DSI. Association between the angiotensin-converting enzyme (insertion/deletion) and angiotensin II type 1 receptor (A1166C) polymorphisms and breast cancer among Brazilian women. J Renin Angiotensin Aldosterone Syst 2009, 10:51-58. 10.1177/1470320309102317, 19286759.
28. Yaren A, Turgut S, Kursunluoglu R, Oztop I, Turgut G, Kelten C, Erdem E. Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients. Tohoku J Exp Med 2006, 210:109-116. 10.1620/tjem.210.109, 17023764.
29. Cheon KT, Choi KH, Lee HB, Park SK, Rhee YK, Lee YC. Gene polymorphisms of endothelial nitric oxide synthase and angiotensin-converting enzyme in patients with lung cancer. Lung 2000, 178:351-360. 10.1007/s004080000039, 11361058.
30. Ding XJ. Analysis of the relationship between the polymorphism of angiotensin-converting enzyme gene and lung cancer (Chinese). 2008,
31. Rocken C, Neumann K, Carl-McGrath S, Lage H, Ebert MP, Dierkes J, Jacobi CA, Kalmuk S, Neuhaus P, Neumann U. The gene polymorphism of the angiotensin I-converting enzyme correlates with tumor size and patient survival in colorectal cancer patients. Neoplasia 2007, 9:716-722. 10.1593/neo.07418, 1993856, 17898867.
32. Vairaktaris E, Serefoglou Z, Avgoustidis D, Yapijakis C, Critselis E, Vylliotis A, Spyridonidou S, Derka S, Vassiliou S, Nkenke E, et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol 2009, 45:247-253. 10.1016/j.oraloncology.2008.05.003, 18674955.
33. Zhang QZ, Liu XM, Zhang ZG, Wang LH. Analysis of the relationship between polymorphism of angiotensin-converting enzyme gene and lung cancer(Chinese). Zhong Guo Fei Ai Za Zhi 2005, 8:211-214.
34. Bardi E, Jenei C, Kiss C. Polymorphism of angiotensin converting enzyme is associated with severe circulatory compromise in febrile neutropenic children with cancer. Pediatr Blood Cancer 2005, 45:217-221. 10.1002/pbc.20400, 15806540.
35. Holla L, Vasku A, Soucek M, Krahulcova E, Hajek D, Znojil V. Angiotensin-converting enzyme gene polymorphism and blood groups of the ABO system in Leukaemias compared with controls and hypertensives. Scripta Medica(Brno) 1998, 71:471-477.
36. Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, Friedman E, Narod S, Olshen AB, Gregersen P, et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 2008, 105:4340-4345. 10.1073/pnas.0800441105, 2393811, 18326623.
37. Landa I, Ruiz-Llorente S, Montero-Conde C, Inglada-Perez L, Schiavi F, Leskela S, Pita G, Milne R, Maravall J, Ramos I, et al. The variant rs1867277 in FOXE1 gene confers thyroid cancer susceptibility through the recruitment of USF1/USF2 transcription factors. PLoS Genet 2009, 5:e1000637. 10.1371/journal.pgen.1000637, 2727793, 19730683.
38. Le Marchand L. Genome-wide association studies and colorectal cancer. Surg Oncol Clin N Am 2009, 18:663-668. 10.1016/j.soc.2009.07.004, 2756243, 19793573.
39. Turner AJ, Hooper NM. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci 2002, 23:177-183. 10.1016/S0165-6147(00)01994-5, 11931993.
40. Campa D, Vodicka P, Pardini B, Naccarati A, Carrai M, Vodickova L, Novotny J, Hemminki K, Försti A, Barale R, et al. A gene-wide investigation on polymorphisms in the taste receptor 2R14 (TAS2R14) and susceptibility to colorectal cancer. BMC Med Genet 2010, 11:88. 2893173, 20534144.
41. Easton DF, Eeles RA. Genome-wide association studies in cancer. Hum Mol Genet 2008, 17:R109-R115. 10.1093/hmg/ddn287, 18852198.
42. Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, Wacholder S, Wang Z, Welch R, Hutchinson A, et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 2007, 39:870-874. 10.1038/ng2075, 17529973.
43. Kiemeney LA, Grotenhuis AJ, Vermeulen SH, Wu X. Genome-wide association studies in bladder cancer: first results and potential relevance. Curr Opin Urol 2009, 19:540-546. 10.1097/MOU.0b013e32832eb336, 19553824.
44. Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet 2009, 41:996-1000. 10.1038/ng.424, 2844110, 19648919.
45. Thomas G, Jacobs KB, Yeager M, Kraft P, Wacholder S, Orr N, Yu K, Chatterjee N, Welch R, Hutchinson A, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008, 40:310-315. 10.1038/ng.91, 18264096.
46. Petersen GM, Amundadottir L, Fuchs CS, Kraft P, Stolzenberg-Solomon RZ, Jacobs KB, Arslan AA, Bueno-de-Mesquita HB, Gallinger S, Gross M, et al. A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet 2010, 42:224-228. 10.1038/ng.522, 2853179, 20101243.
47. Chung CM, Wang RY, Chen JW, Fann CS, Leu HB, Ho HY, Ting CT, Lin TH, Sheu SH, Tsai WC, et al. A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor. Pharmacogenomics J 2010, 10:537-544. 10.1038/tpj.2009.70, 20066004.
48. Feulner TM, Laws SM, Friedrich P, Wagenpfeil S, Wurst SH, Riehle C, Kuhn KA, Krawczak M, Schreiber S, Nikolaus S, et al. Examination of the current top candidate genes for AD in a genome-wide association study. Mol Psychiatry 2010, 15:756-766. 10.1038/mp.2008.141, 19125160.
49. Ruiter R, Visser E, Van Duijn M, HCh Stricker B. The ACE Insertion/Deletion Polymorphism and Risk of Cancer, a Review and Meta-Analysis of the Literature. Current Cancer Drug Targets 2011, 11:421-430. 10.2174/156800911795538147, 21395549.
50. Meyer BR, Vashishtha A, Hillis G, Al-Mohammad A, Jennings K, Ohishi M, Rakugi H, Higaki J, Miki T, Ogihara T. Angiotensin-Converting-Enzyme Genotype and Ischemic Heart Disease. New Engl J Med 1995, 333:458-460.